European CPNP Approval Granted for Derma Products
Filed with ASX · · 3 pages · English
Story so far
Earlier from Argent Biopharma
- MXC Operations Update
- New Panax Acquisition Agreement Signed, Settlement Imminent
- First Major European Sales and Revenue for MGC Derma Range
- Cleansing Prospectus
- EU Registration Commenced for CBD Derma Product Sales
Later from Argent Biopharma
- Commencement of Dermatological Clinical Trials
- Panax Acquisition Completed
- Medical Cannabis Clinical Study Commencing
- Cannabinoid Extraction Facility On Target Q2 Production
- Australian Legislation Changes Fast Track MXC
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma